A PROVEN PLATFORM.
CyberKnife’s precise delivery allows the expansion of radiosurgery and SBRT treatments to indications not possible to treat on other radiation therapy systems.
Page 1 of 11
LAS VEGAS CYBERKNIFE® EXPERIENCE WITH CYBERKNIFE VOLO™ OPTIMIZATION: INCREASE IN PATIENT THROUGHPUT & DAILY VOLUMES
We caught up on all the news about the Phase 3 Randomized PACE Trial on SBRT in Patients with Localized Prostate Cancer, with Dr. Nicholas van As, Medical Director and Consultant Clinical Oncologist of The Royal Marsden NHS Foundation Trust and Lead investigator of the PACE trial.